• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

    • Radiology
      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

U.S. Diabetic Neuropathy Market 2023 Insights Business Opportunities, Current Trends And Restraints Forecast 2028 | Eli Lilly and Company, Johnson & Johnson Services, Inc., Novartis AG, Pfizer, Inc

January 18th, 2023 Coherent Market Insights Releases

Over the projection period, growth in the U.S. diabetic neuropathy market is anticipated to be driven by ongoing research and development for novel medications by key market participants. For instance, the biotechnology company Biogen declared in September 2021 that the phase 2 CONVEY study of vixotrigine had yielded topline good results. Vixotrigine, a non-opioid experimental oral pain medication for the treatment of diabetes mellitus-associated small fibre neuropathy, was evaluated for efficacy and safety in the CONVEY project, a phase 2 placebo-controlled, double-blind, enhanced enrollment, randomised withdrawal study (SFN).

Get Research Sample PDF with Market Development Insights @ https://www.coherentmarketinsights.com/insight/request-sample/5356

Impact

The financial standing of companies in all industries, including the private healthcare sector, has been harmed by the COVID-19 epidemic and lockdowns in numerous nations throughout the world.

However, because to an increase in diabetic neuropathy research and development, the COVID-19 pandemic had a favourable effect on the diabetic neuropathy market in the United States. For instance, COVID-19 patients’ diabetic neuropathy symptoms have gotten worse in 2022, according to data from U.S. Neuropathy Centers. Neuropathy can be brought on by diabetes, autoimmune conditions, cancer, and other infections. Because the immune system is weakened and patients may be more susceptible to getting infected, there is a potential rise in the demand for diabetic neuropathy medications.

Key Developments

The GBS|CIDP Foundation International launched a campaign in Pennsylvania in January 2022 to raise awareness about focal neuropathy. The purpose of this effort was to increase knowledge of and funding for focal neuropathy research. A uncommon condition known as focal neuropathy causes the immune system of the patient to target several motor neurons, leading to asymmetrical weakening in the patient’s limbs.

The U.S. diabetic neuropathy market is anticipated to grow in use of inorganic tactics such product approval by significant industry players over the forecast period. For instance, the biopharmaceutical company Lexicon Pharmaceuticals, Inc. reported in December 2020 that the U.S. Food and Drug Administration has approved the development of LX9211 for the treatment of diabetic peripheral neuropathic pain. For the treatment of diabetic peripheral neuropathic pain, LX9211 is a strong, orally administered, selective small molecule inhibitor of adapter-associated kinase 1 (AAK1).

Direct Purchase This Report with Huge Discount ( Up To 25% Off) @ https://www.coherentmarketinsights.com/insight/buy-now/5356

Key Takeaways

Due to the growing educational initiatives by the major market participants, the U.S. diabetic neuropathy market is anticipated to have a CAGR of 5.2% over the course of the projected period. For instance, in May 2022, the pharmaceutical company Averitas Pharma, Inc. held the “Speak for Your Feet” competition for New Jersey’s diabetic nerve pain sufferers, carers, and healthcare professionals (HCPs). This training programme aims to raise awareness of possible diabetic nerve pain symptoms and to establish a common language between patients and medical practitioners.

Peripheral neuropathy is thought to maintain a leading position among types in the U.S. diabetic neuropathy market as a result of the use of inorganic techniques including product approval by regulatory bodies like the U.S. Food and Drug Administration. For instance, the pharmaceutical company Pfizer, Inc. announced in July 2019 that the U.S. Food and Medicine Administration has approved the use of the drug Lyrica for the treatment of neuropathic pain brought on by diabetic peripheral neuropathy.

Averitas Pharma, Inc., Eli Lilly and Company, Tissue Tech, Inc., Johnson & Johnson Services, Inc., NeuroMetrix, Inc., Novartis AG, Ionis Pharmaceuticals, Pfizer, Inc., Alembic Pharmaceuticals Limited, GSK plc, Abbott, Glenmark Pharmaceuticals Ltd., Regenacy Pharmaceuticals, Inc., and Lupin, are significant market participants in the U.S. diabetic neuropathy market.

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5356

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug
      • Market Snapshot, By Type
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • Impact Analysis
    • Partnership and Collaboration Scenario
    • Recent Product Launches and Approvals
    • Market Trends
    • Regulatory Scenario
    • PEST Analysis
    • Reimbursement Scenario
    • Cost of therapy
    • Brand Mapping
  4. U.S. Diabetic Neuropathy Market – Impact of Coronavirus (Covid-19) Pandemic
    • Overall Impact
    • Impact on Supply and Demand
    • COVID-19 Impact on the market
  5. U.S. Diabetic Neuropathy Market, By Drug, 2017 – 2030, (US$ Million)
    • Overview
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Tricyclic Antidepressants
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Amitriptyline
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Nortyptyline
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Imipramine
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Desipramine
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • SSRI
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Paroxetine
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Citalopram
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Anticonvulsants
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Gabapentin
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Pregabalin
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Carbamazepine
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Others (Oxcarbazepine, Topiramate and Others)
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Opioids
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Tramadol
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Tapentadol
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Oksikodon
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • SNRIs
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Duloxetine
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Other Drugs
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million
        • Capsaicin
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Lidocaine
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
        • Botilinum Toxin
          • Overview
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
  6. U.S. Diabetic Neuropathy Market, By Type, 2017 – 2030, (US$ Million)
    • Overview
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Peripheral Neuropathy
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Proximal Neuropathy
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Autonomic Neuropathy
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Focal Neuropathy
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
  7. U.S. Diabetic Neuropathy Market, By Route of Administration, 2017 – 2030, (US$ Million)
    • Overview
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Oral
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Topical
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Injection (Intramuscular)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
  8. U.S. Diabetic Neuropathy Market, By Distribution Channel, 2017 – 2030, (US$ Million)
    • Overview
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2017 – 2030
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
    • Online Pharmacies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)

View Press Release: https://www.coherentmarketinsights.com/press-release/us-diabetic-neuropathy-market-4655

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
Email: sales@coherentmarketinsights.com
Phone: U.S.: +1-206-701-6702
U.K.: +44-020-8133-4027
JAPAN: +81-50-5539-1737
INDIA: +91-848-285-0837

Sign up and submit a press release

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email